Inventprise

Inventprise announces the completion of vaccination in their Phase 2 dose ranging study of its 25-valent pneumococcal conjugate vaccine (IVT PCV-25) in young adults. The study is being conducted in four sites in Canada. This Phase 2 study is an important step in the efforts to develop an affordable, expanded-coverage pneumococcal conjugate vaccine (PCV). This vaccine is designed to help prevent pneumococcal disease caused by serotypes not covered in the current PCVs and to help provide protection to people globally, including in low- and middle-income regions where the pneumococcal disease burden is greatest. #vaccines #globalhealth #pneumonia #innovation For more information see the complete Press Release: https://lnkd.in/grEDAwux

📢 Exciting News from Inventprise! Inventprise is thrilled to announce the kickoff of the First-in-Human clinical trial for its Group B Streptococcus (GBS) vaccine candidate! The trial will take place at NYU Langone and at Wits VIDA, South Africa, and will measure the safety and immunogenicity of this innovative new vaccine for women of child-bearing age. GBS bacterium is carried by ~20% of women worldwide and can be passed to infants before and during childbirth, causing meningitis, lifelong disabilities, sepsis, and infant deaths. We are proud to partner with PATH on this landmark study, funded by the Bill & Melinda Gates Foundation. Our vaccine development partnership is one step on the journey toward making a GBS vaccine widely available. Special thanks to our incredible R&D, Clinical, PMO, Regulatory, MSAT, Manufacturing, and Quality teams for their hard work in making this milestone possible. Next stop—New York! 🗽 #Inventprise #GBSVaccine #ClinicalTrials #WomensHealth #GlobalHealth #PATH #GatesFoundation

🌟 We’re Hiring! Could You Be Our Next Director of Materials Management? 🌟 Inventprise is seeking a strategic and experienced leader to join us as the Director of Materials Management. Why Join Inventprise? ·   Competitive rewards ·   Healthy, inclusive company culture ·   Opportunity to make a significant impact with our innovative, growing company About the Role: As Director of Materials Management, you’ll lead our Materials strategy, ensuring seamless planning, procurement, and warehouse operations. Your responsibilities will include: ·   Optimizing supply chains and managing Materials & Warehouse teams. ·   Supporting R&D, Manufacturing, and Facilities by ensuring material availability. ·   Driving cost-effective solutions and improving inventory performance. ·   Building vendor relationships, developing procurement requirements, and creating success metrics. Join leading experts in Science, R&D, Medicine, and Manufacturing as you contribute to world-class innovations. 🚀 Ready for your next career adventure? Learn more and apply here: https://lnkd.in/giM8zGSj #WeAreHiring #JoinOurTeam #InventpriseCareers #SupplyChainLeadership #BiotechJobs

🌟 We’re Hiring! Could You Be Our Next VP of Quality? 🌟 Inventprise is looking for a dedicated leader to join our team as the Vice President of Quality. Why Inventprise? ·   Competitive rewards ·   Healthy and inclusive culture ·   Opportunity to make a meaningful impact with our innovative, growing company About the Role: As VP of Quality, you’ll lead Inventprise’s Quality strategy, ensuring our standards, practices, and products meet the highest levels of excellence and FDA compliance. This pivotal leadership role involves: ·   Shaping and implementing Quality best practices for vaccine development. ·   Collaborating with R&D, Manufacturing, Clinical, and other key teams. ·   Driving a Quality-focused culture and strategic plan. Join a team of top experts in Science, R&D, Medicine, and Manufacturing, and help us deliver world-class innovations. Are you ready for the challenge? Learn more and apply here: https://lnkd.in/gmtRkm5d #WeAreHiring #JoinOurTeam #InventpriseCareers #LeadershipOpportunities #BiotechJobs

🎁 Inventprise Elves Hard at Work for Those in Need 🦃🎄 As the holidays approach, we take time to reflect on the blessings of family, friends, and abundance. This season, Inventprise is proud to give back by supporting the Holiday Giving Tree initiative, in conjunction with Meadowbrook Community Care and their Lake City Holiday Project! Together, we’re spreading joy and ensuring holiday cheer for those in need—with toys for children, gifts for adults, and food for families. Wishing you and yours joy and happiness this holiday season. Let’s make the season brighter for everyone. ❤️ #InventpriseCares #HolidayGiving #CommunitySupport #SeasonOfGiving

🎉 Inventprise at the First International Klebsiella Pneumoniae Symposium🌍 We were honored to attend the inaugural International Klebsiella pneumoniae Symposium this week at the Institut Pasteur in Paris, France. This groundbreaking three-day event shed light on why K. pneumoniae is a significant global health threat, particularly due to antimicrobial resistance and its role in neonatal sepsis mortality. Our Klebsiella Vaccine Project Lead, Heather Fox presented the status of our glycoconjugate maternal vaccine, aimed at preventing neonatal sepsis in lower and middle-income countries. Her presentation was part of a special session sponsored by the Bill & Melinda Gates Foundation, alongside experts Ziyaad Dangor and Francesca Micoli. With more than 800 attendees joining in person and online, the symposium covered critical topics like clinical implications, genomics, and epidemiology of K. pneumoniae. This collaboration and knowledge-sharing are essential steps in tackling this devastating disease and advancing global health efforts. 💉🦠   #GlobalHealth #KlebsiellaPneumoniae #Vaccines #NeonatalSepsis #InnovationForLife

🌍 Partnerships for Progress: World Pneumonia Day 2024 🌍 Each year on this day, we unite globally to raise awareness about pneumonia, a preventable and treatable illness that tragically claims the lives of more than 800,000 children annually. #WorldPneumoniaDay serves as a call to action to support access to vaccines, improve treatments, and advocate for healthcare equity worldwide. This year’s theme is “Partnerships for Progress,” and Inventprise is proud of its strong ties with influential partners, such as PATH and Gavi, the Vaccine Alliance, among others. At Inventprise, we're dedicated to preventing infectious diseases and advancing global health. Our high-valent pneumococcal conjugate vaccine candidate, IVT PCV-25, is for pediatric populations globally, and currently undergoing clinical trial. Leveraging our proprietary Linker Conjugation Platform, this vaccine promises broader coverage, a stronger immune response, and a longer-lasting defense against pneumonia. Together with our key partners, we aim to create a healthier future, especially for those most vulnerable. 💙 Join us in the fight against pneumonia. Spread awareness. Support vaccination programs. Advocate for accessible healthcare for all. Learn more at: https://stoppneumonia.org #WorldPneumoniaDay #EndPneumonia #Inventprise #VaccinesSaveLives #GlobalHealth #PneumoniaAwareness #HealthyFutures #VaccinationMatters #HealthcareForAll

🌍 Inventprise recently participated in the World Vaccine Congress Europe in Barcelona! 💉 This premier event brought together more than 3,000 global leaders, industry pioneers, and experts in vaccine R&D to discuss groundbreaking advancements and collaborate on making vaccine innovation accessible to all. During the congress, Inventprise connected with key partners like UNICEF, the Bill & Melinda Gates Foundation, PATH, and the World Health Organization, focusing on shared goals of advancing global health through cutting-edge vaccines. Together, we’re working towards a future where the latest scientific insights in vaccinology benefit communities worldwide. Special thanks to Olivier Brun for representing Inventprise’s European presence.   #Inventprise #WorldVaccineCongress #Vaccines #GlobalHealth #Innovation

💉Vaccine Access for All🌏 Last week, Inventprise had the privilege of joining the annual UNICEF Vaccine Industry Consultation in Copenhagen. Our CEO, Yves Leurquin, along with experts Jon Pearman and Olivier Brun, engaged with more than 130 industry leaders focused on how we can collectively ensure sustainable access to life-saving vaccines for Low & Middle Income Countries (LMICs). Key partners and donors, such as Gavi, the Vaccine Alliance, World Health Organization (WHO), and Bill & Melinda Gates Foundation were also present, engaging in powerful discussions on the future of vaccine technology, production, and delivery. This three-day event was an incredible opportunity to align on a shared goal: sustainable and equitable access to vaccines for all children, ensuring a future free from vaccine-preventable diseases. Together, we are making strides toward a healthier, more equitable world. 🌏💉 #VaccinesForAll #GlobalHealth #Inventprise #VaccineEquity #ChildHealth

🍩 Sweets & SWAG? Yes Please! 🎉 Last week, Inventprise employees networked in style with delicious Top Pot Donuts and some fresh company swag! Donuts were devoured as our Redmond and Woodinville teams came together to network, connect with leadership, and show off their Inventprise spirit. 🍩👕 Our new shirts proudly showcase our mission: “Empower people to live healthy lives by inventing better vaccines.” 💉💪 #Inventprise #TeamSpirit #DonutsAndSwag #MissionDriven #BetterVaccines #TopPotDonuts Leticia Jefferson Matias Olave subhash kapre Kraig Norris Rachael Moss, MBA SPHR Maitreyee Barve Ashley Dsilva Alisha Keene Preethi Jayaraman Connor Shay Ramesh Shanbhag PE, CEng Conner Reyes